ENTRY       D10309                      Drug
NAME        Brexpiprazole (JAN/USAN/INN);
            Rexulti (TN)
PRODUCT     REXULTI (Otsuka America Pharmaceutical)
            REXULTI (REMEDYREPACK)
  GENERIC   BREXPIPRAZOLE (Ajanta Pharma USA)
            BREXPIPRAZOLE (Amneal Pharmaceuticals NY LLC)
FORMULA     C25H27N3O2S
EXACT_MASS  433.1824
MOL_WEIGHT  433.5658
CLASS       Neuropsychiatric agent
             DG01483  5-HT1A-receptor agonist
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 1179
            ATC code: N05AX16
            Product: D10309<JP/US>
EFFICACY    Antipsychotic
  DISEASE   Major depressive disorder [DS:H01646]
            Schizophrenia [DS:H01649]
COMMENT     Serotonin-dopamine activity modulator (SDAM)
            Treatment of schizophrenia, psychiatric disorders
TARGET      DRD2 [HSA:1813] [KO:K04145]
            HTR1A [HSA:3350] [KO:K04153]
            HTR2A [HSA:3356] [KO:K04157]
  PATHWAY   hsa04080(1813+3350+3356)  Neuroactive ligand-receptor interaction
            hsa04726(3350+3356)  Serotonergic synapse
            hsa04728(1813)  Dopaminergic synapse
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2D6 [HSA:1565]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N05 PSYCHOLEPTICS
               N05A ANTIPSYCHOTICS
                N05AX Other antipsychotics
                 N05AX16 Brexpiprazole
                  D10309  Brexpiprazole (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antipsychotics
              2nd Generation/Atypical
               Brexpiprazole
                D10309  Brexpiprazole (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1179  Others
                 D10309  Brexpiprazole (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01483  5-HT1A-receptor agonist
               D10309  Brexpiprazole
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               D10309  Brexpiprazole
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D10309  Brexpiprazole
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Dopamine
                DRD2
                 D10309  Brexpiprazole (JAN/USAN/INN) &lt;JP/US&gt;
               Serotonin
                HTR1A
                 D10309  Brexpiprazole (JAN/USAN/INN) &lt;JP/US&gt;
                HTR2A
                 D10309  Brexpiprazole (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10309
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10309
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10309
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10309
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10309
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D10309
DBLINKS     CAS: 913611-97-9
            PubChem: 172232423
ATOM        31
            1   C8y C    16.9400  -18.4800
            2   C8x C    16.9400  -17.0800
            3   C8x C    15.7500  -16.3800
            4   C8x C    15.7500  -19.1800
            5   C8y C    14.4900  -18.4800
            6   C8y C    14.4900  -17.0800
            7   C8x C    12.1100  -17.0100
            8   C8y C    12.1100  -18.4100
            9   N4x N    13.3000  -19.1800
            10  O5x O    10.8500  -19.1100
            11  O2a O    18.1300  -19.1800
            12  C1b C    19.3900  -18.4800
            13  C1b C    20.5800  -19.1800
            14  C1b C    21.7700  -18.4800
            15  C1b C    23.0300  -19.1800
            16  N1y N    24.2200  -18.4800
            17  C1x C    25.4100  -19.1800
            18  C1x C    26.6700  -18.4800
            19  N1y N    26.6700  -17.0800
            20  C1x C    25.4100  -16.3800
            21  C1x C    24.2200  -17.0800
            22  C8y C    27.8600  -16.3800
            23  C8y C    29.0500  -17.0800
            24  C8y C    30.3100  -16.3800
            25  C8x C    30.3100  -14.9800
            26  C8x C    29.0500  -14.2800
            27  C8x C    27.8600  -14.9800
            28  C8x C    13.3000  -16.3800
            29  C8x C    29.3300  -18.4800
            30  C8x C    30.7300  -18.6900
            31  S2x S    31.3600  -17.3600
BOND        35
            1     5   4 2
            2    14  15 1
            3     5   6 1
            4    15  16 1
            5    28   7 2
            6     7   8 1
            7     8   9 1
            8     9   5 1
            9     4   1 1
            10   16  17 1
            11   17  18 1
            12   18  19 1
            13   19  20 1
            14   20  21 1
            15   21  16 1
            16    8  10 2
            17   19  22 1
            18    1  11 1
            19    1   2 2
            20   11  12 1
            21    2   3 1
            22   22  23 2
            23   23  24 1
            24   24  25 2
            25   25  26 1
            26   26  27 2
            27   27  22 1
            28   12  13 1
            29    3   6 2
            30   13  14 1
            31    6  28 1
            32   23  29 1
            33   29  30 2
            34   30  31 1
            35   24  31 1
///
